» Articles » PMID: 11728000

Applications of Yeast in Drug Discovery

Overview
Journal Prog Drug Res
Specialty Pharmacology
Date 2001 Dec 1
PMID 11728000
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The yeast Saccharomyces cerevisiae is perhaps the best-studied eukaryotic organism. Its experimental tractability, combined with the remarkable conservation of gene function throughout evolution, makes yeast the ideal model genetic organism. Yeast is a non-pathogenic model of fungal pathogens used to identify antifungal targets suitable for drug development and to elucidate mechanisms of action of antifungal agents. As a model of fundamental cellular processes and metabolic pathways of the human, yeast has improved our understanding and facilitated the molecular analysis of many disease genes. The completion of the Saccharomyces genome sequence helped launch the post-genomic era, focusing on functional analyses of whole genomes. Yeast paved the way for the systematic analysis of large and complex genomes by serving as a test bed for novel experimental approaches and technologies, tools that are fast becoming the standard in drug discovery research

Citing Articles

Insight into the Antioxidant Effect of Fermented and Non-Fermented Water and Ethanol Extracts at the Proteome Level Using a Yeast Cell Model.

Rutar J, Cillero-Pastor B, Mohren R, Poklar Ulrih N, Ogrinc N, Jamnik P Antioxidants (Basel). 2021; 10(9).

PMID: 34572998 PMC: 8465041. DOI: 10.3390/antiox10091366.


Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches.

Hofer S, Kainz K, Zimmermann A, Bauer M, Pendl T, Poglitsch M Front Mol Neurosci. 2018; 11:318.

PMID: 30233317 PMC: 6131589. DOI: 10.3389/fnmol.2018.00318.


Quantitative Gene Expression of ERG9 in Model Saccharomyces cerevisiae: Chamomile Extract For Human Cancer Treatment.

Hosseinpour M, Mobini-Dehkordi M, Teimori H J Clin Diagn Res. 2016; 10(7):FC05-8.

PMID: 27630863 PMC: 5020243. DOI: 10.7860/JCDR/2016/18149.8187.


The effect of bioactive compounds on in vitro and in vivo antioxidant activity of different berry juices.

Slatnar A, Jakopic J, Stampar F, Veberic R, Jamnik P PLoS One. 2012; 7(10):e47880.

PMID: 23110118 PMC: 3479138. DOI: 10.1371/journal.pone.0047880.


Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease.

Garrido-Maraver J, Cordero M, Monino I, Pereira-Arenas S, Lechuga-Vieco A, Cotan D Br J Pharmacol. 2012; 167(6):1311-28.

PMID: 22747838 PMC: 3504996. DOI: 10.1111/j.1476-5381.2012.02086.x.